As tennis stars disagree over a proposed fighting fund for players during the coronavirus shutdown, it remains clear most lower-ranked professionals struggle to make ends meet plying their trade.

Cycling's governing body responds to the coronavirus pandemic, announcing a jam-packed 100-day schedule with a string of major races — including two Grand Tours — in October alone.

The restart of the NRL could be jeopardised as Raiders forwards Sia Soliola, Joe Tapine and Josh Papalli join Titans forward Bryce Cartwright in refusing to sign an unedited version of the vaccination waiver.

Three Gold Coast Titans players, including Bryce Cartwright, have been stood down for refusing to have a flu shot only a day after the NRL announced its revised stance on vaccinations.

Your Zoom or Skype meetings don't have to look like hostage videos. Here's what some experts advise.

The new version of "Valley Girl" reconfigures the '80s teen classic as a flashback jukebox musical, but it lacks the spark and charm of the original without finding a new tune to call its own.

Matt Wolf's latest documentary, "Spaceship Earth," is a layered and absorbing account of a widely dismissed but remarkable scientific study.

Matt Santoro is one of numerous Canadian YouTube celebrities who will be in town for the second annual event.

While featuring all sides of an issue is a hallmark of good journalism, many in the scientific community feel that the media should do a better job of separating facts from opinions.

The World Health Organization joined with global leaders to accelerate production of vaccines and treatments aimed at stamping out the coronavirus.

Israeli scientists say they can mimic the effects of a vaccination campaign if certain people willingly get infected with the coronavirus and recover.

Before a single case of coronavirus, President Nayib Bukele placed El Salvador in lockdown and has engaged in other moves that critics say are authoritarian.

Coronavirus: There is a price to pay for pledging too much as the world anxiously awaits even a marginally effective therapeutic for the disease known as COVID-19.

A desperate attempt to halt coronavirus cases is underway on the country's largest reservation, which spans Arizona, New Mexico and Utah.

Risk guides much of our medical care system. COVID-19 is showing us, unless we have developed immunity, we are all at risk.

This is kinda shocking, but Carnival Cruise enthusiasts aren't letting the pandemic scare 'em away from boarding ships with hundreds of passengers. A rep with Cruise Planners, an American Express travel franchise, tells TMZ ... after Carnival…

Revolutionizing cardiac device data management

Revolutionizing cardiac device data management

With 34 years of programming experience in various organizations, Cal shares what he's observed of leaders who are looking to be reinvigorated, what to do when job-inspiration is lost and taking an educated leap of faith.

Keep on reading: Quick Answers to Quick Questions: In Conversation with Cal Evans, Senior Consultant, E.I.C.C., Inc.

The current pandemic is revealing the level of commitment needed from multiple sectors to deliver innovative solutions to tackle severe shortages of personal protective equipment, ventilators, and raw materials. Researchers at the Prakash lab at Stanford University are no stranger to taking up extreme challenges, and they have kept up their reputation by coming up […]

Prisym ID, a provider of data-led label and artwork management solutions, is offering instant access to its Prisym 360 SaaS medical devices labelling solution, to support medtech manufacturers’ response to Covid-19.

The Advanced Medical Association (AdvaMed) has requested the United States Trade Representative (USTR) provides additional tariff exclusions for medical devices, components and supplies coming from China which are necessary to help with Covid-19.

Roche’s antibody test for Covid-19 has been given the CE mark and has been issued Emergency Use Authorisation from the US Food and Drug Administration.

Rapid News Group has announced the decision to postpone Med-Tech Innovation Expo, the UK’s flagship event for the medical device industry to 2021.

AdvaMed has announced the launch of a new platform, which will attempt to connect ventilator companies with component suppliers to ensure quick scale production and distribution of these devices during the Covid-19 pandemic.

New era for lymphoma, leukemia, possibly other cancers

Agency moves toward more accelerated reviews

For continued prevention of recurrent VTE

Myth: ‘Gene Patents’ are not necessary for health care innovation. Facts: Patents on DNA preparations or sequences are often the first patents upon which a later technology platform or portfolio is built.  These patents are often in-licensed from universities by small start-up companies for the purpose of additional R&D, evidencing that the public/non-profit university sector cannot bear […]

Posted by Stephanie Fischer on June 10, 2011 at 3:29pm EDT on BIOtech Now The U.S. Supreme Court issued a favorable decision yesterday in the critical case of Microsoft v. i4i, in which Microsoft challenged the “clear and convincing evidence” standard traditionally used by courts in determining whether to invalidate an issued U.S. patent.   Microsoft argued for a lower “preponderance […]

NHS England has expanded access to targeted hormone therapies for advanced prostate cancer

The approval gives NSCLC patients whose tumours carry the MET exon 14 skipping mutation a new treatment option

If you’re looking for a Lyme disease vaccine, you can choose from among several—for your dog. A vaccine for humans hasn’t been available for years and few companies have tried to fill that void. Valneva has advanced its Lyme vaccine candidate to mid-stage clinical testing, and the company now has the help of drug giant […]

As cancer research reveals the genetic basis of the disease, pharmaceutical companies are pursuing targeted therapies that address certain groups of patients. One such drug from Novartis won FDA approval Wednesday, making it the first therapy cleared by the agency to treat patients whose non-small cell lung cancer (NSCLC) carries a certain genetic mutation. The […]

Trovagene (NASDAQ: TROV), which started out as a diagnostics company, has renamed itself Cardiff Oncology to better reflect its focus on the cancer drug it is advancing in three clinical trials. In 2017 the San Diego area-based biotech made the first step in its transformation into a drug development-focused organization, licensing rights to an investigational […]

In this video explainer, Christopher Robertson discusses the Right to Try Act and off-label use of pharmaceuticals with Alison Bateman-House.

The post Access to Drugs Before FDA Approval: Video Explainer with Christopher Robertson appeared first on Bill of Health.

uBiome, a San Francisco startup that sells commercial tests that use DNA sequencing to identify what microbes are in a person's stool or, for one test, in the vagina, has raised $83 million from venture capitalists to fund an entrée into drug development.

The solutions enable continuous remote monitoring of body temperature and other vitals, either at home or in care centers, for clinical trials.

The companyâs SiteVault Free tool, designed to enable collaborating between sites and study monitors, now has a remote monitoring feature.

The pharmaceutical firm has purchased the company, which specializes in advancing treatments and diagnostics for ocular disorders.

The launch of the renamed, newly independent company follows its acquisition by Altaris Capital Partners.

The institutional review board and research technology solutions provider has acquired IRBco to expand its reach and presence in North America.

The 100th anniversary of astronomy’s “Great Debate” prompts thoughts on the hunt for life in the universe

-- Read more on ScientificAmerican.com

WASHINGTON–(BUSINESS WIRE)–The Association of Clinical Research Organizations (ACRO) is pleased to announce that its Board of Directors has elected John Ratliff, CEO of Covance Drug...

On July 17, 2019, under cooperative agreement with the FDA, the Duke-Margolis Center for Health Policy (Duke Margolis) held a public workshop. The event, titled Improving the Implementation of Risk-Based Monitoring Approaches of Clinical Investigations, aimed to identify opportunities to improve Risk Based Monitoring (RBM) implementation and solicit stakeholder input on the challenges, barriers, and enablers that impact the successful adoption of RBM.